Germany's Sarstedt starts building blood collection systems plant in St. Petersburg, opening set for 2022
ST. PETERSBURG. July 22 (Interfax) - Germany's Sarstedt AG started construction of a medical equipment plant in the Maryino industrial park in the Petrodvorets district of St. Petersburg on Monday, an Interfax correspondent reported from the groundbreaking ceremony.
The amount of investment in the plant is now estimated at 21.2 million euros (1.5 billion rubles), which is twice the initial estimate. The cost was estimated at 750 million rubles when a memorandum on construction of the plant was signed by the company, VTB and the St. Petersburg government at the 2018 St. Petersburg International Economic Forum. VTB Group manages the Maryino industrial park.
The plant of about 9,000 square meters will have two production lines to manufacture single-use blood collection systems (venous and capillary).
The German company's CEO, Jurgen Sarstedt said at the groundbreaking that Sarstedt made the decision to localize production in Russia in 2016. In future, the company plans to expand the plant's product line, and expects that its products will not only be supplied to medical institutions in Russia, but also to those of the CIS and other countries that border Russia, he said.
Commercial production is scheduled to begin in May 2022, Sarstedt said.
Sarstedt, a family-owned company founded in 1961, specializes in manufacturing laboratory and medical equipment and supplies for medical and scientific purposes. The company has 33 sales organizations and 13 production facilities in Europe, North America and Australia. The company's headquarters are in the German city of Numbrecht.